TITLE

Four firms in plan to develop embryonic stem cell technology

PUB. DATE
April 2008
SOURCE
Medical Device Daily;4/4/2008, Vol. 12 Issue 66, p6
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on a letter of intent signed by BioTime and its Embryome Sciences subsidiary with International Stem Cell Corp. and its subsidiary Lifeline Cell Technology to jointly produce and distribute a variety of research products from human embryonic stem cell technology. According to Embryome Science and Lifeline, they intend to jointly manufacture products serving the complex needs of the medical device industry.
ACCESSION #
31639847

 

Related Articles

  • Financings roundup.  // Medical Device Daily;1/4/2011, Vol. 15 Issue 2, p3 

    This article reports on an equity financing announced by BioTime from its subsidiary, Embryome Sciences.

  • Intl Stem Cell Corp Announces Second Quarter 2011 Financial Results and Corporate Events.  // Biomedical Market Newsletter;8/23/2011, Vol. 21, p305 

    The article focuses on the financial results and events of International Stem Cell Corp. (ISCO), a biotechnology company based in Carlsbad, California. It states that the company reported year-to-date revenues of 2.6 million dollars for the quarter ending June 30, 2011, driven by sales of ISCO's...

  • Stem cell revival. Coghlan, Andy // New Scientist;10/27/2012, Vol. 216 Issue 2888, p4 

    The article reports on attempts to resume a human embryonic stem cells (hESCs) clinical trial program cancelled in 2011 by the biotechnology company Geron, noting that former Geron officials and the biotechnology firm BioTime have placed a bid for the stem cell assets of the original program.

  • New BioTime subsidiary to target regenerative medicine market.  // Medical Device Daily;12/18/2007, Vol. 11 Issue 229, p6 

    The article reports on a subsidiary called Embryome Sciences established by BioTime, with the mission of participating in the emerging field of regenerative medicine known as embryomics. The subsidiary plans to launch three kinds of research products in 2008 and 2009, including a commercial...

  • Stem Cell Co. Broadens Territory, Begins Selling Products in Japan. Chambers, Heather // San Diego Business Journal;4/12/2010, Vol. 31 Issue 15, p12 

    The article offers news briefs related to business development in the U.S. Lifeline Cell Technology LLC, a subsidiary of International Stem Cell Corp. signed an agreement with Tokyo-based Veritas Corp. to sell its human cell culture products. Intellikine Inc. and Tragara Pharmaceuticals Inc....

  • Japan okays stem cells. Saegusa, Asako // Nature Biotechnology;Mar2000, Vol. 18 Issue 3, p246 

    Reports on the approval given by the bioethics committee of Japan's Science and Technology Council for research involving the use of embryonic stem cells. Reason cited by the committee for granting approval to the research; Plans of the committee to draw up guidelines for embryonic stem cell...

  • Scientists react to government indecision. Brown, Phyllida // Nature Medicine;Aug99, Vol. 5 Issue 8, p855 

    Discusses the government's delay in deciding whether to permit research into the therapeutic use of human embryonic stem cells in Great Britain. Creation of anti-science climate; Reaction of the researchers towards the delay.

  • Corrigendum: Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells. Osakada, Fumitaka; Ikeda, Hanako; Mandai, Michiko; Wataya, Takafumi; Watanabe, Kiichi; Yoshimura, Nagahisa; Akaike, Akiori; Sasai, Yoshiki; Takahashi, Masayo // Nature Biotechnology;Mar2008, Vol. 26 Issue 3, p352 

    A correction to the article "Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells" that was published in the February 3, 2008 issue is presented.

  • Court paints with broad brush, upends U.S. stem cell policy. Lefkowitz, Jay // Hill;9/16/2010, Vol. 17 Issue 100, p31 

    In this article the author focuses on the court ruling which emphasized the preclusion of an embryonic stem cell research project from receiving federal fundings by the Dickey-Wicker Amendment if one step of the project results in the destruction of an embryo in the U.S.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics